AzTrials
AzTrials

Knee OsteoarthritisKNEE-CYCLENCT07838012

Feasibility of an Early Home-based Cycling Intervention After Knee Arthroplasty

A study testing Early home-based stationary cycling in people with Knee Osteoarthritis and Knee Arthroplasty, run by Central Jutland Regional Hospital at 1 site in Denmark.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this pilot clinical trial is to evaluate whether an early, home-based stationary cycling programme, provided in addition to standard postoperative home exercises, is feasible and acceptable for patients recovering from knee arthroplasty. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Knee Osteoarthritis, Knee Arthroplasty
What is being tested?
Early home-based stationary cycling
Could I receive a placebo?
No, everyone receives an active treatment
How many people
24 participants
Where
1 siteDenmark
Study dates
21 Sep 2026to Mar 2028
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Scheduled for unilateral primary medial unicompartmental knee arthroplasty (UKA) or total knee arthroplasty (TKA).
  • Age ≥ 18 years.
  • Able to speak and read Danish.
  • Daily access to a stationary bike during the intervention period, or willingness to use a stationary bike provided by the study through an external rental company for the duration of the intervention. Due to logistical constraints, loan bikes can only be provided to participants residing within approximately one hour of transport from Aarhus or Silkeborg. Participants living outside this area may participate if they have access to a stationary bike.
  • Ability to use a smartphone with internet connectivity (required for completion of electronic questionnaires and using SENS motion application) or a tablet and having an email address enabling completion of electronic questionnaires.

Who cannot join

  • Previous surgery in either lower limb within 3 months before the date of knee arthroplasty or planned surgery in either lower limb within 3 months after the date of knee arthroplasty.
  • Inflammatory joint disease
  • Previous osteotomy around the knee or tibial condyle fracture that has been treated with osteosynthesis in the affected knee.
  • Medical or physical conditions that would prevent safe participation in the cycling intervention (e.g., unstable cardiovascular, pulmonary, or chronic neurodegenerative disorders).
  • Active cancer treatment, if this treatment would interfere with safe participation or adherence to the cycling protocol.
  • Preoperative reduced knee flexion preventing full pedal rotation on a stationary bike.
  • Current or recent history of alcohol and/or substance misuse, as identified during the anaesthetic pre-assessment and documented in the electronic patient record.
  • Cognitive impairment (e.g. dementia) or diagnosed psychiatric disorder that would prevent the patient from understanding or adhering to the cycling protocol.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Mette Garval, MSc contact

+45 29773935

metgar@rm.dk

Denmark1 site, 1 recruiting
  • Regional Hospital Silkeborg

    Silkeborg, Central Jutland, 8600

    Mette Garval, MSc, 0045 29773935, metgar@rm.dk

    David H Christiansen, Professor, 0045 2168 8431, David.Christiansen@midt.rm.dk

    Recruiting

Other trials in Denmark

About this study

Official title: Feasibility of Adding Early Home-based Cycling to Standard Exercises After Knee Arthroplasty: A Pilot Randomised Controlled Trial

The goal of this pilot clinical trial is to evaluate whether an early, home-based stationary cycling programme, provided in addition to standard postoperative home exercises, is feasible and acceptable for patients recovering from knee arthroplasty. It will also inform the design of a larger clinical trial examining the effects of adding early cycling to standard postoperative home exercises on postoperative outcomes.

The main questions it aims to answer are:

Read more
  • Can the cycling programme and planned study procedures be delivered as intended?
  • Are participants willing and able to take part in the study and follow the planned interventions?
  • Do participants find the cycling programme and outcome assessments acceptable?
  • What changes, if any, are needed before conducting a larger clinical trial?

Researchers will compare an early home-based stationary cycling programme provided in addition to standard postoperative home exercises with standard postoperative home exercises alone.

Participants will:

  • Be randomly assigned to either the cycling group or the standard exercise group (control group) two weeks after surgery.
  • If assigned to the cycling group, perform 30 minutes of stationary cycling at home at least five days per week for eight weeks in addition to the standard postoperative home exercise programme.
  • If assigned to the control group, follow the standard postoperative home exercise programme and refrain from structured cycling during the eight-week intervention period.
  • Complete questionnaires and physical assessments at baseline and follow-up visits.
  • Complete selected patient-reported outcome measures at 6 and 12 months after surgery.
Read the detailed description

This pilot randomised clinical trial will evaluate the feasibility, acceptability, and safety of an early, home-based stationary cycling intervention added to standard postoperative home exercises following knee arthroplasty. The study will also evaluate the feasibility of the study procedures required for a subsequent full-scale randomised clinical trial.

A total of 24 participants will be randomised in a 1:1 ratio to either the cycling intervention group or the control group. Both groups will receive the standard postoperative home exercise programme. Participants allocated to the cycling intervention group will additionally perform the structured home-based cycling programme for eight weeks. Participants allocated to the control group will follow the standard postoperative home exercise programme without structured cycling during the intervention period. Outcome assessors conducting the 10-week follow-up assessments will be blinded to group allocation.

The pilot will address several aspects of feasibility, including screening and recruitment, retention and completion of follow-up, adherence to the allocated study intervention, acceptability of the cycling intervention, safety, and the practicality and burden of study procedures. In the control group, adherence to the instruction to refrain from cycling during the intervention period will also be assessed. The study will additionally examine the practical and logistical feasibility of delivering the cycling intervention at home, including access to stationary bikes and, where required, provision of bikes through an external rental service.

Participants will complete selected patient-reported outcome measures preoperatively and undergo a baseline assessment two weeks after surgery, before randomisation. Preoperative assessments are included for measures for which assessment two weeks after surgery is not considered appropriate or informative. Following the baseline assessment and randomisation, participants will receive the allocated intervention. The main follow-up assessment will be conducted at 10 weeks after surgery, following completion of the eight-week cycling intervention.

Recruitment feasibility will be assessed throughout the recruitment period, including screening, eligibility, recruitment rate, and reasons for declining participation. Retention will be assessed by attendance at the 10-week follow-up and completion of planned assessments.

Intervention feasibility will include adherence to the prescribed cycling dose using the SENS Motion® activity tracker, participant-reported symptoms related to cycling, and acceptability of the intervention. In the control group, adherence to the instruction to refrain from cycling will also be assessed. Safety will be assessed by recording and describing adverse events and serious adverse events occurring during the study, including events potentially related to the cycling intervention.

Feasibility of the study procedures will include completion and burden of questionnaires and physical and performance assessments, as well as the duration and practical challenges associated with baseline and follow-up assessments, intervention delivery, equipment, and study visits. The practical and logistical feasibility of providing stationary bikes through an external rental service will also be evaluated. Participant feedback, qualitative interviews, and feedback from project staff and the clinical team will provide additional information on practical aspects of study conduct.

Completion of patient-reported outcome measures will be assessed as a separate feasibility aspect. Overall completion, completion of individual questionnaires, and missing questionnaire items will be examined to identify measures or items that may be difficult to complete, perceived as less relevant, or contribute substantially to assessment burden. These findings may inform refinement of the outcome assessment battery for the subsequent full-scale trial.

Predefined progression criteria will be used to guide the decision whether to progress to a future full-scale randomised clinical trial. The criteria address recruitment rate, adherence in the intervention and control groups, 10-week follow-up completion, and completion of baseline physical and performance assessments. A traffic-light system will be used to indicate whether progression is feasible as planned, may require modifications or further clarification, or is not recommended in its current form. The progression criteria will be considered together with additional qualitative and practical information collected during the pilot.

The primary feasibility evaluation will take place at 10 weeks after surgery. Clinical and patient-reported outcomes collected during the pilot will be analysed descriptively to provide exploratory information on postoperative recovery, outcome variability, and potential between-group differences. The Knee injury and Osteoarthritis Outcome Score (KOOS) will be assessed using the Pain, Symptoms, Activities of Daily Living (ADL), and Quality of Life subscales preoperatively and at the 10-week follow-up. These four subscales comprise the KOOS4. The proportion of participants achieving a minimally important change in KOOS4 will be explored descriptively.. These data will also contribute to planning the outcome assessment and statistical design of the subsequent full-scale randomised clinical trial.

Selected patient-reported outcome measures will also be collected at 6 and 12 months after surgery. These data will provide exploratory information on longer-term outcomes and the feasibility of longer-term follow-up. The longer-term follow-up will not determine the main feasibility evaluation at 10 weeks.

Overall, the findings from the pilot will be used to determine whether modifications to the intervention, study procedures, recruitment or retention strategies, or outcome assessment battery are required before conducting a subsequent full-scale randomised clinical trial.

Being tested
Early home-based stationary cycling, Usual care: home-based exercise programme
Keywords
Knee arthroplasty, Postoperative rehabilitation, Home-based rehabilitation, Stationary cycling, Feasibility study, Postoperative recovery
Medical subject headings
Osteoarthritis, Knee

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Early home-based stationary cyclingOther

    Participants will receive individual instruction in the cycling protocol from a physiotherapist in addition to the standard postoperative home-based exercise programme described for the control group. Beginning two weeks after knee arthroplasty, participants will perform 30 minutes of home-based stationary cycling at least five days per week for eight weeks. Cycling will initially be performed at a comfortable pace with no resistance and a cadence of approximately 50-60 rpm, with cadence and resistance gradually increasing as tolerated. If unable to complete full pedal rotations, participants will perform pendulum exercises twice daily for five minutes until sufficient knee flexion is achieved. A traffic-light symptom guide will be used to adjust cycling according to pain and swelling. Participants will not be routinely referred to supervised rehabilitation during the intervention period but may contact the physiotherapy team for advice or attend a consultation if clinically indicated.

  • Usual care: home-based exercise programmeOther

    Participants will follow the standard post-operative home-based exercise programme, consisting of five exercises targeting knee range of motion and quadriceps strength, performed twice daily. At the two-week post-operative follow-up, participants will receive instruction in a second exercise programme. The exercises prescribed will be individually adjusted by a physiotherapist according to the participant's recovery and readiness for progression, including knee range of motion, functional capacity, and pain. Participants will not be routinely referred to supervised rehabilitation during the intervention period but may contact the physiotherapy team for advice or attend an additional consultation if clinically indicated.

Study groups in NCT07838012
Study groupRoleWhat they receive
Early home-based stationary cyclingExperimentalParticipants will begin a home-based stationary cycling programme two weeks after knee arthroplasty. They will perform 30 minutes of stationary cycling at least five days per week for eight weeks, in addition to the standard postoperative home-based exercise programme.
Receives: Other: Early home-based stationary cycling
Usual care: home-based exercise programmeActive comparatorParticipants will follow the standard postoperative home-based exercise programme beginning two weeks after knee arthroplasty. The programme focuses on knee mobility and muscle activation and does not include the stationary cycling intervention.
Receives: Other: Usual care: home-based exercise programme

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Screening and eligibility rate

    The number of patients screened per week and the proportion who are eligible.

    Measured: From study initiation until completion of recruitment.

  2. Recruitment rate

    Number of eligible patients providing verbal agreement to participate per week and proportion of eligible patients providing verbal agreement to participate.

    Measured: From study initiation until completion of recruitment.

  3. Declined participation among eligible patients

    Number and proportion of eligible patients who decline participation after receiving study information.

    Measured: From study initiation until completion of recruitment.

  4. Baseline assessment completion

    Proportion of participants who provide written informed consent and complete the planned baseline assessment before randomisation. Completion of individual objective and physical performance assessments will also be recorded to identify any assessments that are not completed.

    Measured: At baseline, before randomisation

  5. Retention and completion of 10-week follow-up assessments

    Proportion of randomised participants who attend the 10-week follow-up assessment and proportion who complete all planned objective and physical performance assessments, reported separately for the intervention and control groups. Reasons for non-attendance and incomplete assessments will also be recorded.

    Measured: 10 weeks after surgery

  6. Adherence to the cycling intervention

    Objective adherence to the prescribed cycling intervention, including frequency and duration of cycling sessions and the proportion of prescribed cycling days completed, assessed using the SENS Motion® sensor system.

    Measured: 2 to 10 weeks after surgery.

  7. Cycling-related pain, swelling and discomfort

    Participant-reported pain, swelling and discomfort related to cycling, assessed during a structured telephone assessment approximately one week after initiation of the cycling intervention. Responses will be recorded descriptively. Participants unable to complete full pedal rotations will be contacted again one week later.

    Measured: Approximately 1-2 weeks after initiation of the cycling intervention.

  8. Acceptability of the cycling intervention

    Participant-reported acceptability of the home-based cycling intervention assessed using selected items from the Theoretical Framework of Acceptability (TFA) questionnaire. The items assess affective attitude, burden, perceived effectiveness, self-efficacy, and overall acceptability. Responses are recorded on five-point Likert scales.

    Measured: 10 weeks after surgery.

  9. Completion of patient-reported outcome measures

    Proportion of participants who complete all planned patient-reported outcome measures (PROMs) at baseline and 10-week follow-up. Completion of individual PROMs and missing questionnaire items will also be recorded to identify PROMs with incomplete data.

    Measured: Baseline and 10 weeks after surgery

  10. Participant-reported burden of outcome assessments

    Participant-reported burden of the questionnaires and objective assessments, assessed using two yes/no questions on whether the assessments were so burdensome that the participant would choose not to participate in a similar study again. Participants answering "yes" will be asked to provide a brief reason.

    Measured: Baseline and 10 weeks after surgery

  11. Adverse events and postoperative complications

    Adverse events and postoperative complications reported by participants or identified in electronic health records during the study period. Events will be recorded and summarised descriptively.

    Measured: From randomisation to 10 weeks after surgery.

Secondary outcomes (18)
  1. Knee-related pain, symptoms, function and quality of life

    Knee-related pain, symptoms, function in activities of daily living, and knee-related quality of life assessed using four subscales of the Knee injury and Osteoarthritis Outcome Score (KOOS): Pain, Symptoms, Activities of Daily Living, and Quality of Life. Each subscale is scored from 0 to 100, with higher scores indicating better outcomes. The KOOS4 is calculated from these four subscales. The individual four KOOS subscale scores will also be reported.

    Measured: Pre-operatively, 10 weeks, 6 months, and 12 months after surgery.

  2. Health-related quality of life

    Health-related quality of life assessed using the EuroQol 5-Dimension 5-Level questionnaire (EQ-5D-5L). Each of the five dimensions is scored from 1 to 5, with higher scores indicating greater severity of problems. The five dimensions assess mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Self-rated health will also be assessed using the EQ visual analogue scale (EQ VAS), scored from 0 to 100, with higher scores indicating better self-rated health.

    Measured: Pre-operatively, 10 weeks, 6 months, and 12 months after surgery.

  3. Mental well-being

    Mental well-being assessed using the World Health Organization-Five Well-Being Index (WHO-5). The raw score ranges from 0-25, with higher scores indicating better mental health. The raw score will be transformed to a percentage score from 0-100, with higher scores indicating better mental well-being.

    Measured: Pre-operatively, 10 weeks, 6 months, and 12 months after surgery.

  4. Early recovery

    Patient-reported early postoperative recovery assessed using the Oxford Arthroplasty Early Recovery Score (OARS). The overall 14-item OARS is scored from 0 to 100, with higher scores indicating better recovery.

    Measured: Baseline, 6 and 10 weeks after surgery.

  5. Early change in recovery

    Patient-reported change in early postoperative recovery assessed using the Oxford Arthroplasty Early Change Score (OACS). The OACS is scored from -50 to 50, with higher scores indicating greater improvement. A score of 0 indicates no change from preoperative health status.

    Measured: Baseline, 6 and 10 weeks after surgery.

  6. Pain intensity

    Self-reported knee pain intensity at rest, during activity, and at its worst during the previous 24 hours, assessed using an 11-point Numeric Rating Scale (NRS; 0-10).

    Measured: Pre-operatively, at baseline, and at 6 and 10 weeks and 6 and 12 months postoperatively.

  7. Pain distribution

    Presence and distribution of pain during the previous week, assessed using a pain mannequin covering predefined body regions. Participants indicate whether pain is present and, where applicable, whether it affects the left side, right side, or both sides.

    Measured: Pre-operatively, at 10 weeks and 6 and 12 months after surgery.

  8. Pain medication use

    Use of pain medication assessed using categorical patient-reported questions. Participants will report whether they use pain medication (yes/no), whether the medication is taken because of knee pain (no/yes/both knee pain and other pain), and the frequency of use of over-the-counter pain medication and strong opioid pain medication. Frequency of use is categorised as never or rarely, several times per month, several times per week, once daily, or several times daily. Use of strong opioid pain medication is assessed as no, yes, or do not know, followed by the same frequency categories for participants reporting use.

    Measured: Pre-operatively, at baseline, and at 6 and 10 weeks and 6 and 12 months after surgery.

  9. Knee range of motion

    Knee range of motion assessed using goniometric measurement, reported in degrees (°). Knee flexion and extension range of motion will be measured.

    Measured: Baseline and 10 weeks after surgery.

  10. Knee range of motion

    Patient-reported knee range of motion assessed using the Copenhagen Knee Range of Motion Scale (CKRS), a pictorial questionnaire in which participants select the image that best represents their knee range of motion. Knee flexion is scored from 0 to 6, with higher scores indicating greater knee flexion, and knee extension is scored from 0 to 5, with higher scores indicating greater knee extension.

    Measured: Pre-operatively, 6 weeks, 6 months, and 12 months after surgery.

  11. Knee swelling

    Knee swelling assessed by circumference measurements of the operated and non-operated knees.

    Measured: Baseline and 10 weeks after surgery.

  12. 40-metre fast-paced walk test

    Walking performance assessed using the 40-metre fast-paced walk test.

    Measured: Baseline and 10 weeks after surgery.

  13. 30-second chair stand test

    Physical performance assessed using the 30-Second Chair Stand Test, measured as the number of full chair stands completed in 30 seconds. Higher scores indicate better physical performance.

    Measured: 10 weeks after surgery.

  14. Stair climb test

    Physical performance assessed using the Stair Climb Test, measured as the time in seconds required to ascend a predefined 9 stairs. Lower scores indicate better physical performance.

    Measured: 10 weeks after surgery.

  15. Pain sensitivity

    Pain sensitivity assessed using quantitative sensory testing (QST) with cuff algometry.

    Measured: Baseline and 10 weeks after surgery.

  16. Physical activity level

    Physical activity level assessed using the one-item University of California, Los Angeles (UCLA) Activity Scale. The scale ranges from 1 to 10, with higher scores indicating a higher level of physical activity.

    Measured: Pre-operatively, and at 10 weeks, 6 months, and 12 months after surgery.

  17. Objective physical activity

    Objective physical activity assessed using the SENS Motion® sensor system. Activity data collected during the final week of the 8-week intervention period will be used to assess daily step count and time spent at different activity intensity levels.

    Measured: During the final week of the 8-week intervention period.

  18. Patient satisfaction and perceived outcome

    Participants' overall assessment of their operated knee, including pain and ability to perform activities of daily living, compared with before surgery, assessed 7-point Global Perceived Effect (GPE) scale scored from 0 to 6, with higher scores indicating a better perceived outcome. At 6 and 12 months after surgery, patient satisfaction and perceived treatment outcome will additionally be assessed using questions addressing satisfaction with the surgical result, willingness to undergo surgery again given the experienced treatment course and outcome, an acceptable current state of knee function, and perceived treatment failure.

    Measured: 10 weeks, and 6 and 12 months after surgery.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Sep 2026
  2. Study start21 Sep 2026
  3. Primary completionMay 2027 (estimated)
  4. Study completionMar 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Model description
Participants will be randomly assigned in a 1:1 ratio to one of two parallel groups, with randomisation stratified by type of knee arthroplasty (unicompartmental knee arthroplasty \[UKA\] or total knee arthroplasty \[TKA\]). The cycling intervention group will receive an eight-week home-based stationary cycling programme in addition to standard post-operative home exercises. The control group will receive standard postoperative home exercises alone and will be asked to refrain from cycling during the eight-week intervention period.
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
24 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07838012
Sponsor's protocol ID
654615
Other IDs
A4560, R248-A9052, R251-A9053
Acronym
KNEE-CYCLE
Status last verified
Oct 2026
First submitted
3 Sep 2026
Last updated
2 Oct 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Individual participant data will not be made available to other researchers. No plan is in place to share individual participant data outside the research group.

Questions about this trial

What is this clinical trial studying?

A study testing Early home-based stationary cycling in people with Knee Osteoarthritis and Knee Arthroplasty, run by Central Jutland Regional Hospital at 1 site in Denmark.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 2 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Denmark. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Mette Garval, MSc (+45 29773935, metgar@rm.dk), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Screening and eligibility rate (time frame: From study initiation until completion of recruitment.). The study lists 11 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Oct 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in